AstraZeneca Q2 Profit Surges, Signs Gene Therapy Deal With Pfizer; Stock Up

(RTTNews) - Shares of AstraZeneca Plc were gaining around 4 percent in London trading as well as around 5 percent in pre-market activity on Nasdaq after the British drug major reported Friday significantly higher profit for its second quarter. Top line beat market estimates. Furt https://www.nasdaq.com/articles/astrazeneca-q2-profit-surges-signs-gene-therapy-deal-with-pfizer-stock-up